Reticuloendotheliosis/NN
virus/NN
long/JJ
terminal/JJ
repeat/NN
elements/NNS
are/VBP
efficient/JJ
promoters/NNS
in/IN
cells/NNS
of/IN
various/JJ
species/NNS
and/CC
tissue/NN
origin/NN
,/,
including/VBG
human/JJ
lymphoid/JJ
cells/NNS
./.

Promiscuous/JJ
transcriptional/JJ
activity/NN
of/IN
the/DT
reticuloendotheliosis/NN
virus/NN
(/(
REV/NN
)/)
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
was/VBD
detected/VBN
in/IN
transient/JJ
expression/NN
assays/NNS
using/VBG
LTR-chloramphenicol/NN
acetyltransferase-encoding/JJ
gene/NN
chimeras/NNS
,/,
and/CC
cells/NNS
of/IN
diverse/JJ
species/NNS
and/CC
tissue/NN
type/NN
;/:
levels/NNS
of/IN
expression/NN
from/IN
two/CD
different/JJ
REV/NN
LTRs/NNS
correlate/VBP
with/IN
reports/NNS
of/IN
pathogenicity/NN
of/IN
the/DT
respective/JJ
viruses/NNS
in/FW
vivo/FW
./.
=====
REVs/NNS
do/VBP
not/RB
encode/VB
a/DT
transactivator/NN
targeted/VBN
to/TO
the/DT
viral/JJ
LTR/NN
,/,
and/CC
cells/NNS
infected/VBN
with/IN
Marek/NN
's/POS
disease/NN
virus/NN
,/,
a/DT
herpesvirus/NN
with/IN
an/DT
overlapping/VBG
host/NN
range/NN
,/,
do/VBP
not/RB
express/VB
factors/NNS
that/WDT
preferentially/RB
enhance/VBP
expression/NN
from/IN
REV/NN
or/CC
avian/JJ
sarcoma/leukemia/NN
virus/NN
LTRs/NNS
./.
=====
REV/NN
LTRs/NNS
work/VBP
efficiently/RB
in/IN
human/JJ
lymphoid/JJ
cells/NNS
,/,
and/CC
are/VBP
viable/JJ
alternatives/NNS
to/TO
promoters/NNS
commonly/RB
used/VBN
for/IN
expression/NN
of/IN
cloned/VBN
genes/NNS
./.
=====
They/PRP
may/MD
also/RB
prove/VB
useful/JJ
in/IN
the/DT
identification/NN
of/IN
new/JJ
,/,
ubiquitous/JJ
cellular/JJ
transcription/NN
factors/NNS
./.